In a recent installment of the International Society of Automation’s “Ask the Automation Pros” series, Erik Cornelsen, ...
Mortgage rates dropped to 6.01% after the GSEs announced $200B in MBS purchases, fueling hopes of more refinances and better ...
The center uses the claims submission technology to automatically turn its clinical information into data appropriate for ...
On January 7, OpenAI introduced ChatGPT Health, a feature within the chatbot that enables users to upload health records from apps like Apple Health and Function, and receive personalized medical ...
Heritage Insurance holds a $35 target with a 76.8% combined ratio, 6x forward earnings, and potential 2025 EPS beats. Find ...
Professor Ibrahim Adeola Katibi, a renowned cardiologist, teaches at the University of Ilorin in Kwara State. He is a former ...
Nearly two decades of data show retired households face frequent “rainy day,” family and health shocks, often without enough ...
The Ethereum price witnessed a renewed recovery trendline as buyers breached a key resistance amid the growth of new wallets ...
Researchers developed TLC-2716, a liver- and gut-targeted drug that selectively reduced LXR activity, lowering triglycerides, ...
The December inflation data was weaker than anticipated and confirms that tariffs are not having the immediate impact on ...
Ireland’s climate experience closely follows the global trend, with 2025 the country’s second-warmest year on record ...
News Medical on MSN
First-in-human drug trial lowers high blood fats
In a Phase 1 clinical study, researchers led by EPFL and their partners report that a new liver- and gut-targeted oral drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results